(Q40284624)

PubMed ID

26028995

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028995%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Finding the Wolf in Sheep's Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer (English)

1 reference

PubMed ID

26028995

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028995%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Sanoj Punnen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

Nicola Pavan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

Dipen J Parekh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

publication date

1 January 2015

1 reference

PubMed ID

26028995

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028995%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

page(s)

3-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

14 May 2020

cites work

1 reference

12 December 2020

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

1 reference

12 December 2020

Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men.

1 reference

12 December 2020

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen

1 reference

12 December 2020

Active surveillance for prostate cancer: a systematic review of the literature

1 reference

12 December 2020

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

1 reference

12 December 2020

1 reference

12 December 2020

A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening

1 reference

12 December 2020

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

1 reference

12 December 2020

Decision curve analysis: a novel method for evaluating prediction models

1 reference

12 December 2020

Long-term functional outcomes after treatment for localized prostate cancer

1 reference

12 December 2020

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer

1 reference

12 December 2020

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

1 reference

12 December 2020

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

1 reference

12 December 2020

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

Radical prostatectomy or watchful waiting in early prostate cancer

1 reference

12 December 2020

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

1 reference

12 December 2020

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

1 reference

12 December 2020

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer

1 reference

12 December 2020

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study

1 reference

12 December 2020

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms

1 reference

12 December 2020

Biomarkers in prostate cancer surveillance and screening: past, present, and future.

1 reference

12 December 2020

Radical prostatectomy versus observation for localized prostate cancer

1 reference

12 December 2020

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

12 December 2020

Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer

1 reference

12 December 2020

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

1 reference

12 December 2020

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range

1 reference

12 December 2020

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospectiv

1 reference

12 December 2020

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

1 reference

12 December 2020

Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis

1 reference

12 December 2020

Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.

1 reference

12 December 2020

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

1 reference

12 December 2020

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models

1 reference

12 December 2020

Cancer statistics, 2014

1 reference

12 December 2020

The epidemiology of high-risk prostate cancer

1 reference

12 December 2020

Screening and prostate-cancer mortality in a randomized European study

1 reference

12 December 2020

Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry

1 reference

12 December 2020

Risk-based prostate cancer screening.

1 reference

12 December 2020

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

1 reference

12 December 2020

Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020

Prostate specific antigen best practice statement: 2009 update

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC4444768&resulttype=core&format=json

14 May 2020

1 reference